Anti-C17 could dose dependently inhibit the infection of CCR5-tropic JRFL virus at an IC50 of 0.40 μM without any inhibition on CXCR4-tropic HXB2 virus (Figure 2A; Table 1). The gene discussed is CCR5; the disease is infection.